|
JPS5238680B2
(pl)
|
1972-12-27 |
1977-09-30 |
|
|
|
US4732155A
(en)
|
1985-08-27 |
1988-03-22 |
The Children's Medical Center Corporation |
Implantable chemoattractant system
|
|
US5658894A
(en)
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
|
US5661127A
(en)
|
1995-05-01 |
1997-08-26 |
The Regents Of The University Of California |
Peptide compositions with growth factor-like activity
|
|
JP3018313B2
(ja)
|
1996-02-23 |
2000-03-13 |
雪印乳業株式会社 |
骨形成促進及び骨吸収防止剤
|
|
US6875753B1
(en)
|
1996-03-14 |
2005-04-05 |
The Governors Of The University Of Alberta |
Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
|
|
US20050101564A1
(en)
|
1996-04-02 |
2005-05-12 |
Pilarski Linda M. |
Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
|
|
PT1074268E
(pt)
|
1998-03-17 |
2008-02-28 |
Chugai Pharmaceutical Co Ltd |
Agentes profilácticos ou terapêuticos para doenças intestinais inflamatórias contendo anticorpos antagonistas do receptor il-6
|
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
BR0012787A
(pt)
|
1999-07-28 |
2002-07-30 |
Univ Leland Stanford Junior |
Agonistas de receptor de nicotina no recrutamento de célula tronco e de célula progenitora
|
|
AU1472501A
(en)
|
1999-11-05 |
2001-05-14 |
Gerigene Medical Corporation |
Augmentation and repair of age-related soft tissue defects
|
|
EP1114862A3
(de)
|
1999-11-17 |
2003-08-06 |
Switch Biotech Aktiengesellschaft |
Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
|
|
BR0108545A
(pt)
|
2000-02-24 |
2004-06-29 |
Xcyte Therapies Inc |
Estimulação e concentração simultâneas das células
|
|
JP3421741B2
(ja)
|
2000-05-18 |
2003-06-30 |
筑波大学長 |
人工骨髄、血球細胞の増殖方法
|
|
US20040191246A1
(en)
|
2003-02-26 |
2004-09-30 |
Connelly Patrick R. |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
US7754217B2
(en)
|
2001-03-16 |
2010-07-13 |
Bio3 Research Srl |
HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
|
|
DE10121254A1
(de)
|
2001-04-30 |
2002-11-07 |
Switch Biotech Ag |
MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind
|
|
AU2002304710A1
(en)
|
2001-04-30 |
2002-11-11 |
Switch Biotech Ag |
Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
|
|
BR0209689A
(pt)
|
2001-05-15 |
2006-02-07 |
Long Island Jewish Res Inst |
Uso de fragmento de hmg como agente anti-inflamatório
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
US7220723B2
(en)
|
2001-05-15 |
2007-05-22 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
ITMI20011986A1
(it)
|
2001-09-25 |
2003-03-25 |
San Raffaele Centro Fond |
Metodo e composizione per l'attivazione di cellule presentanti l'antigene
|
|
US20040265971A1
(en)
|
2001-11-19 |
2004-12-30 |
Hidetaka Sato |
Drug mobilizing pluripotent stem cells from tissue into peripheral blood
|
|
KR100811995B1
(ko)
|
2001-12-07 |
2008-03-10 |
사이토리 테라퓨틱스, 인크. |
처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
|
|
FR2833609B1
(fr)
|
2001-12-19 |
2004-12-03 |
Natural Implant |
Dispositif de prelevement cellulaire ou tissulaire en phase active et utilisations
|
|
KR20050054907A
(ko)
*
|
2002-07-03 |
2005-06-10 |
폰다지오네 센트로 산 라파엘 델 몬테 테이보 |
조직 손상의 치료 및/또는 조직 회복의 촉진에서ｈｍｇｂ1 단백질의 용도
|
|
DE60327075D1
(de)
|
2002-07-05 |
2009-05-20 |
Univ Laval |
Der entzündungsreaktionen
|
|
AU2003294246A1
(en)
|
2002-11-01 |
2004-06-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circulating stem cells and uses related thereto
|
|
GB0226251D0
(en)
|
2002-11-11 |
2002-12-18 |
San Raffaele Centro Fond |
Acetylated protein
|
|
US20040156851A1
(en)
|
2002-11-20 |
2004-08-12 |
Critical Therapeutics, Inc. |
HMGB1 combination therapies
|
|
WO2004046345A2
(en)
|
2002-11-20 |
2004-06-03 |
Critical Therapeutics, Inc. |
Use of hmgb fragments as anti-inflammatory agents
|
|
US7470538B2
(en)
|
2002-12-05 |
2008-12-30 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
|
WO2004061456A2
(de)
|
2003-01-03 |
2004-07-22 |
Alcedo Biotech Gmbh |
Verwendungen von hmgb, hmgn, hmga proteinen
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
CN1193092C
(zh)
|
2003-03-28 |
2005-03-16 |
浙江大学 |
骨髓间充质干细胞分离和体外扩增培养方法
|
|
EP1608397B1
(en)
|
2003-03-28 |
2008-10-15 |
Universite Laval |
S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
|
|
US20090069227A9
(en)
|
2003-04-29 |
2009-03-12 |
Capogrossi Maurizio C |
Use of HMGB1 to promote stem cell migration and/or proliferation
|
|
AU2004242091C1
(en)
|
2003-05-07 |
2009-12-24 |
La Jolla Institute For Molecular Medicine |
Administration of hyaluronic acid to enhance the function of transplanted stem cells
|
|
US20050014255A1
(en)
|
2003-05-29 |
2005-01-20 |
Board Of Regents, The University Of Texas System |
Stem cells for clinical and commercial uses
|
|
US20060183667A1
(en)
|
2003-07-11 |
2006-08-17 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
WO2005025604A2
(en)
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
EP1668035A2
(en)
|
2003-09-11 |
2006-06-14 |
Critical Therapeutics, Inc. |
Monoclonal antibodies against hmgb1
|
|
ITRM20040058A1
(it)
|
2004-02-03 |
2004-05-03 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
|
|
WO2006008779A1
(en)
|
2004-07-20 |
2006-01-26 |
Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione-Istituto Dermopatico Dell'immacolata |
Use of hmgb1 for wound healing
|
|
MX2007001155A
(es)
|
2004-07-29 |
2007-08-14 |
Creabilis Therapeutics Spa |
Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
|
|
AU2005279308B2
(en)
|
2004-09-03 |
2012-05-03 |
Creabilis Therapeutics S.R.L. |
Protease resistant human and non-human HMGB1 Box-A mutants and their therapeutic/diagnostic use
|
|
CN101132811B
(zh)
|
2004-10-22 |
2012-05-30 |
米迪缪尼有限公司 |
抗hmgb1的高亲和力抗体及其用法
|
|
KR100593397B1
(ko)
|
2004-10-27 |
2006-06-28 |
한국원자력연구소 |
중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
|
|
WO2006047820A1
(en)
|
2004-11-01 |
2006-05-11 |
Newsouth Innovations Pty Limited |
Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation
|
|
ITRM20050032A1
(it)
|
2005-01-21 |
2006-07-22 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
|
|
US9782439B2
(en)
|
2005-01-27 |
2017-10-10 |
Japan Health Sciences Foundation |
Cell sheet containing mesenchymal stem cells
|
|
ES2345837T3
(es)
|
2005-03-23 |
2010-10-04 |
Biosafe S.A. |
Sistema integrado para la recogida, el procesamiento y el trasplante de subgrupos de celulas, incluyendo celulas madre adultas, para medicina regenerativa.
|
|
WO2006114805A2
(en)
|
2005-04-28 |
2006-11-02 |
Fondazione Centro San Raffaele Del Monte Tabor |
Use of hmgb2 and hmgb3 proteins for medical applications
|
|
US20100280493A1
(en)
|
2005-06-23 |
2010-11-04 |
Asha Nayak |
Methods and Systems for Treating Injured Cardiac Tissue
|
|
EP1909834A2
(en)
|
2005-07-18 |
2008-04-16 |
Critical Therapeutics, Inc. |
Use of hmgb1 antagonists for the treatment of inflammatory skin conditions
|
|
WO2007015546A1
(ja)
|
2005-08-04 |
2007-02-08 |
Genomix Co., Ltd |
間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法
|
|
WO2007031100A1
(en)
|
2005-09-14 |
2007-03-22 |
Ostini, Marco |
Active immunotherapy of life-threatening systemic inflammation
|
|
US20090155853A1
(en)
|
2005-11-18 |
2009-06-18 |
Gary Nabel |
Non-viral gene delivery complex
|
|
CA2631212A1
(en)
|
2005-11-28 |
2007-07-05 |
Medimmune, Llc |
Antagonists of hmgb1 and/or rage and methods of use thereof
|
|
WO2007087367A2
(en)
|
2006-01-25 |
2007-08-02 |
Mount Sinai School Of Medicine |
Methods and compositions for modulating the mobilization of stem cells
|
|
WO2007130725A2
(en)
|
2006-02-06 |
2007-11-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Use of hmgb1 for protection against ischemia reperfusion injury
|
|
JP4982739B2
(ja)
|
2006-06-01 |
2012-07-25 |
国立大学法人 東京医科歯科大学 |
ポリグルタミン病の予防・治療剤
|
|
EP2046834B9
(en)
|
2006-08-11 |
2013-04-10 |
Ono Pharmaceutical Co., Ltd. |
Monoclonal antibodies against stromal derived factor-1 (sdf-1)
|
|
HRP20110487T1
(hr)
|
2006-09-15 |
2011-08-31 |
Creabilis Therapeutics S.R.L. |
Polimerni konjugati hmgb1 box-a i varijanti hmgb1 box-a
|
|
EP2055308B1
(en)
|
2006-10-30 |
2017-05-10 |
Genomix Co., Ltd. |
Pharmaceutical for promoting functional regeneration of damaged tissue
|
|
CA2629652A1
(en)
|
2007-04-24 |
2008-10-24 |
Yaojiong Wu |
Compositions for preventing or treating skin defects and methods of use thereof
|
|
US8114668B2
(en)
|
2007-05-14 |
2012-02-14 |
Cardiac Pacemakers, Inc. |
Composition for cold storage of stem cells
|
|
JP5814549B2
(ja)
|
2008-04-30 |
2015-11-17 |
株式会社ジェノミックス |
損傷組織の機能的再生促進医薬
|
|
KR20110017371A
(ko)
|
2008-04-30 |
2011-02-21 |
가부시키가이샤 제노믹스 |
생체내 기능적 세포의 고효율 채취법
|
|
JP5660889B2
(ja)
|
2008-04-30 |
2015-01-28 |
株式会社ジェノミックス |
末梢循環への骨髄由来多能性幹細胞動員薬
|
|
EP2488209B1
(en)
|
2009-10-16 |
2016-09-28 |
Rutgers, the State University of New Jersey |
Method for treating chronic nerve tissue injury using a cell therapy strategy
|
|
US20120237504A1
(en)
|
2009-10-20 |
2012-09-20 |
Maine Medical Center |
Compositions and methods for treating inflammation and fibrosis
|
|
KR20120135190A
(ko)
|
2009-10-28 |
2012-12-12 |
고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 |
골수 간엽계 및/또는 다능성 줄기세포의 혈중 동원(動員)에 의한 조직 재생 촉진제
|
|
EP2529235B1
(en)
*
|
2010-01-29 |
2019-03-06 |
Metanomics GmbH |
Means and methods for diagnosing heart failure in a subject
|
|
CN102247392A
(zh)
|
2010-05-21 |
2011-11-23 |
中国医学科学院药物研究所 |
甘草酸治疗扩张型心肌病心脏重构和心功能障碍的用途
|
|
JP5950428B2
(ja)
|
2010-08-05 |
2016-07-13 |
日東電工株式会社 |
線維化組織から正常組織を再生するための組成物
|
|
EP2613797B1
(en)
|
2010-09-09 |
2015-11-04 |
University Of Southern California |
Compositions and methods for the removal of biofilms
|
|
KR102113809B1
(ko)
|
2011-04-26 |
2020-05-21 |
가부시키가이샤 스템림 |
조직 재생을 유도하기 위한 펩티드 및 그의 이용
|
|
CN102443064A
(zh)
|
2011-11-03 |
2012-05-09 |
刘誉 |
一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用
|
|
ES2661500T3
(es)
|
2012-07-26 |
2018-04-02 |
Ospedale San Raffaele S.R.L. |
Variantes de HMGB1 y sus usos
|
|
KR101448800B1
(ko)
|
2012-10-24 |
2014-10-13 |
한양대학교 산학협력단 |
핵산 전달 복합체
|
|
CA2889275C
(en)
|
2012-10-25 |
2021-06-15 |
Katsuto Tamai |
Novel method for treating cardiac infarction using hmgb1 fragment
|
|
ES2673861T3
(es)
|
2012-10-25 |
2018-06-26 |
Genomix Co., Ltd. |
Método novedoso para tratar el daño a la médula espinal utilizando el fragmento de hmgb1
|
|
GB2514424A
(en)
*
|
2013-05-25 |
2014-11-26 |
Univ Dublin |
Therapies for Cardiomyopathy
|
|
KR101636139B1
(ko)
|
2013-08-28 |
2016-07-06 |
가톨릭대학교 산학협력단 |
면역조절능이 우수한 sRAGE 과발현 간엽줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
|
|
GB201508337D0
(en)
|
2015-05-15 |
2015-06-24 |
Hmgbiotech S R L |
Novel peptides
|
|
PL3556378T3
(pl)
|
2017-01-27 |
2025-06-09 |
StemRIM Inc. |
Środek do leczenia kardiomiopatii, starego zawału mięśnia sercowego i przewlekłej niewydolności serca
|
|
WO2018186480A1
(ja)
|
2017-04-07 |
2018-10-11 |
株式会社ステムリム |
線維性疾患の治療薬
|
|
CN118460462A
(zh)
|
2017-12-01 |
2024-08-09 |
斯特姆里姆有限公司 |
外胚层间充质干细胞及其产生方法
|
|
US11298403B2
(en)
|
2017-12-01 |
2022-04-12 |
StemRIM Inc. |
Therapeutic agent for inflammatory bowel disease
|
|
WO2019156137A1
(ja)
|
2018-02-08 |
2019-08-15 |
株式会社ステムリム |
乾癬の治療薬
|
|
US12304933B2
(en)
|
2018-10-05 |
2025-05-20 |
StemRIM Inc. |
Disease treatment drug based on mesenchymal-stem-cell mobilization
|
|
WO2020071520A1
(ja)
|
2018-10-05 |
2020-04-09 |
株式会社ステムリム |
間葉系幹細胞の動員活性を有するペプチド
|
|
WO2020158924A1
(ja)
|
2019-01-31 |
2020-08-06 |
国立大学法人大阪大学 |
母児間免疫寛容を誘導する方法
|
|
JP7561348B2
(ja)
|
2019-07-31 |
2024-10-04 |
株式会社ステムリム |
間葉系幹細胞の増殖促進または減少抑制のための組成物
|
|
IL296982B2
(en)
|
2020-04-03 |
2026-04-01 |
Stemrim Inc |
Peptide with mesenchymal stem cell migration activity
|